High Prevalence of Plasmodium falciparum HRP2/3 Gene Deletions in Ethiopia: Implications for Malaria Diagnosis and Treatment—A Systematic Review and Meta‐Analysis
Canadian Journal of Infectious Diseases and Medical Microbiology · 2025-01 · 2025 (1)
DOI: 10.1155/cjid/8677211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Infectious Diseases and Medical Microbiology, online erschienen am 17.10.2025. Verfasst von Habtamu Gebrie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Medicine and Health Sciences, Dilla University, P.O. Box 419, Dilla, Ethiopia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Plasmodium parasite species are the causative agents of malaria, which affects populations worldwide. Rapid diagnostic tests (RDTs), microscopy, and molecular methods have been used to diagnose the disease. HRP2 antigens are unique to P. falciparum , while RDTs can detect lactate dehydrogenase, aldolase, and HRP3. Nevertheless, PfHRP2‐based RDTs may produce false‐negative results if the parasite’s PfHRP2/3 genes are deleted. This study is necessary because there is currently no compiled evidence‐based information regarding PfHRP2/3 gene deletion in Ethiopia.
Methods
Primary research articles on PfHRP2/3 gene deletions (2000–2025) were retrieved from PubMed, Science Direct, and Google Scholar. Eligible studies were systematically searched between May 3 2025, and June 2, 2025. The quality of the included studies was assessed using the Newcastle–Ottawa Scale. Data analysis was performed using STATA Version 17, employing a random effects model. Heterogeneity among studies was evaluated using the I 2 test. To assess publication bias, Begg’s and Egger’s tests were conducted along with funnel plot symmetry analysis.
Results
A total of 932 studies were initially identified, among these 18 studies were selected for full‐text review. After excluding 7 studies, 11 articles were included in the meta‐analysis. The overall pooled prevalence of PfHRP2/3 gene deletions was 35.64% (95% CI: 21.43, 49.85). Specifically, the pooled prevalence of PfHRP2 and PfHRP3 gene deletions was 8.48% (95% CI: 0.96, 16.01) and 23.74% (95% CI: 12.16, 35.32), respectively, while concurrent deletions of both genes account for 8.14% (95% CI: 0.67, 15.61).
Conclusion
This systematic review and meta‐analysis revealed a high prevalence of PfHRP2 /3 gene deletions, highlighting significant challenges to the continued use of PfHRP2/3‐based RDTs in malaria control programs in Ethiopia. Further nationwide surveillance using standardized methodologies is recommended to better understand the extent of these gene deletions and to guide the immediate phasing out of PfHRP2/3‐based RDTs from the national malaria diagnostic algorithm. We also recommend that PCR be considered an essential diagnostic tool in in‐vitro diagnosis (IVD).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, College of Medicine and Health Sciences, Dilla University, P.O. Box 419, Dilla, Ethiopia.
- Department of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, P.O. Box 196, Gondar, Ethiopia.
- Department of Midwifery, College of Medicine and Health Sciences, Dilla University, P.O. Box 419, Dilla, Ethiopia.
- Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Science, University of Gondar, P.O. Box 196, Gondar, Ethiopia.
- Department of Nursing, College of Medicine and Health Science, Dilla University, P.O. Box 419, Dilla, Ethiopia.
- Department of Psychiatry, College of Health and Medical Science, Dilla University, P.O. Box 419, Dilla, Ethiopia.
ORCID-Profile: Habtamu Gebrie, Aberham Abere, Anteneh Gashaw
Zitieren
APA
Gebrie, H., Abere, A., Gashaw, A., Gebremeskele, B. T., Bukayaw, Y. A., Bayable, A., Mekuriaw, B. Y., Yimer, E. G., & Demeke, A. D. (2025). High Prevalence of Plasmodium falciparum HRP2/3 Gene Deletions in Ethiopia: Implications for Malaria Diagnosis and Treatment—A Systematic Review and Meta‐Analysis. Canadian Journal of Infectious Diseases and Medical Microbiology, 2025(1). https://doi.org/10.1155/cjid/8677211
Vancouver
Gebrie H, Abere A, Gashaw A, Gebremeskele BT, Bukayaw YA, Bayable A, et al. High Prevalence of Plasmodium falciparum HRP2/3 Gene Deletions in Ethiopia: Implications for Malaria Diagnosis and Treatment—A Systematic Review and Meta‐Analysis. Canadian Journal of Infectious Diseases and Medical Microbiology. 2025;2025(1). doi:10.1155/cjid/8677211
BibTeX
@article{Gebrie2025,
author = {Gebrie, Habtamu and Abere, Aberham and Gashaw, Anteneh and Gebremeskele, Behailu Taye and Bukayaw, Yeaynmarnesh Asmare and Bayable, Alem and Mekuriaw, Biazin Yenealem and Yimer, Eyob Getaneh and Demeke, Abel Desalegn},
title = {High Prevalence of Plasmodium falciparum HRP2/3 Gene Deletions in Ethiopia: Implications for Malaria Diagnosis and Treatment—A Systematic Review and Meta‐Analysis},
journal = {Canadian Journal of Infectious Diseases and Medical Microbiology},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/cjid/8677211}
}
EUVIMED